首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Neuro-oncology

Neuro-oncology杂志,由Oxford University Press出版,于1999年创刊,Quarterly,出版语言English,ISSN:1522-8517,E-ISSN:1523-5866。

投稿咨询
Neuro-oncology
Neuro-oncology
Neuro-oncology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
13.1
CiteScore
21.1
期刊收录
SCI、SCIE

Neuro-oncology(中文译名:《神经肿瘤学》),ISSN:1522-8517,EISSN:1523-5866,是Oxford University Press出版的国际性学术期刊,创刊于1999年,以Quarterly形式稳定发行,2026年总发文量约184篇。该刊采用非OA开放访问,学科归属为医学 - 临床神经学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达13.1,2025年期刊CiteScore为21.1,2025年期刊自引率约5.3%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Neuro-oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期一般,3-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAGERMANY (FED REP GER)、England、Canada、Japan、France、Italy等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMHARVARD UNIVERSITY、UNIVERSITY OF TEXAS SYSTEM、UNIVERSITY OF TORONTO、DANA-FARBER CANCER INSTITUTE、HELMHOLTZ ASSOCIATION、MAYO CLINIC等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 CLINICAL NEUROLOGY 临床神经病学
1区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CLINICAL NEUROLOGY 临床神经病学 ONCOLOGY 肿瘤学
1区 1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CLINICAL NEUROLOGY 临床神经病学 ONCOLOGY 肿瘤学
1区 1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q1 4 / 296

98.8

学科:ONCOLOGY SCIE Q1 25 / 333

92.6

学科:CLINICAL NEUROLOGY SCIE Q1 7 / 296

97.8

学科:ONCOLOGY SCIE Q1 18 / 333

94.74

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q1 4 / 286

98.8

学科:ONCOLOGY SCIE Q1 20 / 328

94.1

学科:CLINICAL NEUROLOGY SCIE Q1 4 / 286

98.78

学科:ONCOLOGY SCIE Q1 15 / 328

95.58


中国学者近期发文

1
Methodological concerns on overfitting in a cerebrospinal fluid metabolomics study of leptomeningeal metastasi

Author:Zeng, Yaqin; Sun, Peng

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag046

2
A reply to two letters to the editor of Neuro-Oncolog

Author:Yang, Chunhui; Wang, Qi

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag047

3
Efficacy and safety of aumolertinib/icotinib combination therapy for naive EGFR-mutant non-small-cell lung cancer patients with brain metastases: A phase I/II stud

Author:Yu, Min; Chen, Caini; Gong, Youling; Tian, Tian; Li, Yanying; Fan, Hua; Zhang, Lizhi; Deng, Wen; Liu, Yongmei; Peng, Feng; Yu, Yang; Xiu, Weigang; Wang, Yongsheng; Zou, Bingwen; Zhang, Xuanwei; Zhong, Liqiang; Liu, Tianqiong; Wang, Xianfeng; Xu, Yong; Zhou, Lin; Lu, You; Huang, Meijuan

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag036

4
RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathwa

Author:Lin, Jiayi; Liang, Lun; Zhu, Xupeng; Liu, Junjie; Lan, Rongfeng; Wang, Zhenning; Zhang, Dan; Wang, Ying; Hu, Xiaoyan; Huang, Shiyu; Qiu, Linhui; Yang, Shilun; Mou, Yonggao; Chang, Junlei; Yu, Min

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag055

5
Metabolic profiling defines glioblastoma subtypes with distinct prognoses and therapeutic vulnerabilitie

Author:Wu, Fan; Yin, Yi-Yun; Wang, Di; Pan, Chang-Qing; Zhai, You; Yu, Ming-Chen; Wang, Zhi-Liang; Fan, Wen-Hua; Zhao, Zheng; Li, Guan-Zhang; Jiang, Tao; Zhang, Wei

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf294

6
MBD3 deficiency decommissions the nucleosome remodeling and deacetylase complex and orchestrates the epigenetic regulation of gene expression to suppress neuroblastoma progressio

Author:Chen, Chen; Guo, Bize; Wu, Siyan; Zhu, Qinfang; Shi, Hui; Wang, Jinhu; Shu, Qiang; Tao, Ting

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf297

7
Super-enhancer-driven TCF4 orchestrates neuroblastoma metastasis by sphingolipid-dependent membrane remodeling and ITGB1-FAK activatio

Author:Lou, Enzhe; Jiang, Liling; Zheng, Yueyuan; Zhuo, Ran; Zhou, Huan; Hu, Shiwen; Shi, Chunxia; Zhang, Haichuan; Li, Xinyue; Jiang, Lizhen; Mao, Qiong; Liu, Aochu; Liu, Bingyuan; Fang, Jinxin; Pan, Jian; Shi, Xianping

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag021

8
PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilizatio

Author:Hong, Biao; Su, Dongyuan; Cui, Xiaoteng; Zhao, Jixing; Wang, Qixue; Zhan, Qi; Yang, Eryan; Yang, Shixue; Ju, Jiasheng; Huang, Yanping; Cheng, Chunchao; Ding, Yaqing; Xu, Hanyi; Cui, Longtao; Zhao, Yilin; Zhao, Xun; Liang, Siwen; Liu, Yuhao; Kang, Chunsheng

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf253

9
Meningioma microenvironment harbors a rich immune landscape that evolves with biological stat

Author:Guo, Xiaopeng; Moynihan, Zachary A.; Driver, Joseph; Patel, Ruchit, V; Bhave, Varun M.; Maury, Eduardo A.; Knelson, Erik H.; Guo, Hong; Lin, Jia-Ren; Coy, Shannon M.; Wang, Anthony; Gupta, Saksham; Hoffman, Samantha E.; Dunn, Ian F.; Dunn, Gavin P.; Petti, Allegra; Choi, Bryan D.; Choudhury, Abrar; Raleigh, David R.; Wei, Kevin; Reardon, David A.; Barbie, David; Lederer, James A.; Santagata, Sandro; Bi, Wenya Linda

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag022

10
Methodological considerations for large language model-based symptom extraction in neuro-oncology electronic health record

Author:Wang, Xindi; Chang, Zhaoxin; Dong, Hao; Mu, Guangjing; Li, Xingang; Han, Mingzhi

Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag009


在线咨询

Neuro-oncology

国际简称:NEURO-ONCOLOGY参考译名:神经肿瘤学

年发文量:184 CiteScore:21.1 是否预警:否 Gold OA文章占比:39.62% 研究类文章占比:91.30%

杂志社联系方式:OXFORD UNIV PRESS INC, JOURNALS DEPT, 2001 EVANS RD, CARY, USA, NC, 27513

Neuro-oncology